Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from the CTCR-OV01 study

ABSTRACT: All patients with suspected ovarian cancer (Raised CA 125 and a complex pelvic mass in a perimenopausal woman) were radiologically staged using CT scan and a chest x-ray. Patients with evidence of intra-abdominal metastasis and/or malignant pleural effusion were approached for entry to the study. Tissue biopsy was obtained either under radiological control (core needle biopsy) or via laparoscopic surgery (punch biopsy). Patients with histologicaly confirmed epithelial ovarian cancer were randomized to receive either three cycles of carboplatin (AUC 7) or paclitaxel (175 mg/m2). Patients with suspected ovarian cancer had a biopsy obtained before and after 3 cycles of either Carboplatin or Paclitaxel. Samples were immediately frozen for RNA extraction.

ORGANISM(S): Homo sapiens

SUBMITTER: Charlotte Ng 

PROVIDER: E-GEOD-15622 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

The extracellular matrix (ECM) can induce chemotherapy resistance via AKT-mediated inhibition of apoptosis. Here, we show that loss of the ECM protein TGFBI (transforming growth factor beta induced) is sufficient to induce specific resistance to paclitaxel and mitotic spindle abnormalities in ovarian cancer cells. Paclitaxel-resistant cells treated with recombinant TGFBI protein show integrin-dependent restoration of paclitaxel sensitivity via FAK- and Rho-dependent stabilization of microtubules  ...[more]

Similar Datasets

Genomics DNA copy number data from the CTCR-OV01 study
2010-02-28 | GSE18453 | GEO
Transcriptomics Expression data from the CTCR-OV01 study
2009-04-09 | GSE15622 | GEO
Transcriptomics Transcription profiling of human patients recruited to the paclitaxel arm of the CTCR-OV01 study, pre-treatment individuals with ovarian cancer
2008-06-16 | E-GEOD-9455 | biostudies-arrayexpress
Transcriptomics Pre-treatment expression data from patients recruited to the paclitaxel arm of the CTCR-OV01 study
2007-10-30 | GSE9455 | GEO
Other Immune-related gene expression profiling of Epithelial Ovarian Cancer after Neoadjuvant chemotherapy
2022-01-27 | GSE181597 | GEO
Transcriptomics Gene expression profiles of ovarian tumor biopsies from Phase I dasatinib trial
2012-04-11 | E-GEOD-37180 | biostudies-arrayexpress
Transcriptomics Gene expression profiles of ovarian tumor biopsies from Phase I dasatinib trial
2012-04-12 | GSE37180 | GEO
Transcriptomics Gene expression profile of FFPE samples collected with translational purposes from the MITO16/MaNGO-OV2 clinical trial
2023-04-19 | GSE208103 | GEO
Transcriptomics Chemotherapy induced dynamic gene expression changes in vivo are prognostic in ovarian cancer
2014-06-16 | E-GEOD-49577 | biostudies-arrayexpress
Transcriptomics Gene expression associated with acquired paclitaxel resistance in ovarian cancer cell lines
2021-07-02 | GSE172016 | GEO